Imunon, Inc. Effective Income Tax Rate Reconciliation, Other Adjustments, Percent
Imunon, Inc. (IMNN) reported Effective Income Tax Rate Reconciliation, Other Adjustments, Percent of 0.11% for the 12-month period ending 2024-12-31, per its 10-K filed 2025-02-27.
Financial Statements › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments · last filed 2025-02-27
- Imunon, Inc. effective income tax rate reconciliation, other adjustments, percent for fiscal 2024 was 0.11%.
- Imunon, Inc. effective income tax rate reconciliation, other adjustments, percent for fiscal 2023 was -2.90%.
- Imunon, Inc. effective income tax rate reconciliation, other adjustments, percent for fiscal 2019 was 1.10%.
- Imunon, Inc. effective income tax rate reconciliation, other adjustments, percent for fiscal 2018 was -9.40%.
| Period end | Effective Income Tax Rate Reconciliation, Other Adjustments, Percent 12 month | Effective Income Tax Rate Reconciliation, Other Adjustments, Percent 12 month as first filed |
|---|---|---|
| 2024-12-31 | 0.11% 10-K · filed 2025-02-27 | |
| 2023-12-31 | -2.90% 10-K · filed 2025-02-27 | |
| 2019-12-31 | 1.10% 10-K · filed 2021-03-19 | -7.00% 10-K · filed 2020-03-25 |
| 2018-12-31 | -9.40% 10-K · filed 2020-03-25 | |
| 2017-12-31 | 0.00% 10-K · filed 2019-03-29 | |
| 2015-12-31 | 0.00% 10-K · filed 2016-03-30 | |
| 2014-12-31 | 0.00% 10-K · filed 2016-03-30 | |
| 2013-12-31 | 0.00% 10-K · filed 2016-03-30 | |
| 2012-12-31 | 0.00% 10-K · filed 2015-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |